Search
Evommune Inc
EVMNAdd to Watchlist
14.560USD
-0.090-0.62%
Market hours （ET）Quotes delayed by 15 min
528.25MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated:Analyst Rating
Based on
11
analysts
Buy
Current Rating
27.625
Target Price
+88.57%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Evommune Inc
EVMN
11
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Evommune IncEVMN's recent earnings per share performed?
The market expectation was USD -0.89, while Evommune IncEVMN's earnings per share (EPS) for the previous quarter was USD -0.64. EPS for the next quarter is expected at USD -0.67.
What is the analyst rating for Evommune Inc?
Based on the ratings of Evommune Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.